CVS Health Ventures led $40M Funding for H1, the Company Focuses on Monetizing Physician Data

H1 secured $40 million in funding led by CVS Health Ventures, the investment division of CVS/Aetna. The company was previously valued at $750 million following a $100 million funding round spearheaded by Altimeter Capital during the height of the pandemic-driven technology boom in November 2021.

Co-founder and CEO Ariel Katz stated that the nine-year-old health data platform H1 is convinced that not all SaaS projects should be evaluated by a single metric. With this approach, businesses can win the entire focus on H1, which is on providing detailed information about doctors to pharmaceutical companies, healthcare systems, and insurers.
The investment follows several successful projects that CVS Health and H1 have collaborated on, including a new AI model that has led to a substantial improvement in healthcare provider directory accuracy, helping people connect with healthcare providers more quickly.

According to Towards Healthcare, the U.S.  healthcare data monetization market is projected to experience significant growth, with estimates suggesting the market size will increase from USD 158.92 million in 2026 to approximately USD 569.64 million by 2035, representing a compound annual growth rate (CAGR) of 15.24% from 2026 to 2035. Growth is driven by U.S. healthcare providers and payers who are relying heavily on advanced, data-driven insights to optimize costs, manage risk, and improve patient outcomes to secure value-based care reimbursements. Artificial intelligence, machine learning, and scalable cloud networks have created a lucrative market for Data-as-a-Service (DaaS) business models, enabling the processing of unstructured clinical data into actionable assets.

About H1

With the surging demand for Real-World Evidence, the rapid expansion of Artificial Intelligence and cloud analytics, and favorable regulatory initiatives that promote interoperability.

This allows pharmaceutical and biotech companies to identify the best experts for clinical trials, medical affairs, and commercial outreach. It helps track millions of healthcare professionals (HCPs) and healthcare organizations (HCOs) globally.

About CVS Health Ventures

CVS Health Ventures is the corporate venture arm of CVS Health, targeting strategic investments in digital health to support its vertically integrated business model. In the healthcare data monetization sector.
The company focuses on investments that transform care delivery and focus on whole person care, consumer-centric health, and disruptive technology enablement. The fund focuses on startups that utilize AI and analytics to extract actionable insights from clinical, retail, and physician datasets.

A recent report by Towards Healthcare highlights that the U.S. healthcare data monetization market is witnessing growth, with high demand for the transition to value-based care and the push for AI-powered operational workflows. Insights as a service and product detail help healthcare payers manage risks, optimize costs, forecast patient outcomes, and command the largest share of the product-type market.